Results 21 to 30 of about 30,028 (256)

PATTERN OF ANTERIOR UVEITIS IN KMN EYECARE

open access: yesIJRETINA (International Journal of Retina), 2023
Introduction: Anterior uveitis is the most common form of uveitis, but there are relatively few anterior uveitis studies in Indonesia. The purpose of this study is to analyze the pattern of anterior uveitis in KMN EyeCare.
Kevin Kevin, Rifna Lutfiamida
doaj   +1 more source

High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease. [PDF]

open access: yes, 2015
BACKGROUND: Human T-lymphotropic virus type 1 (HTLV-1), a retrovirus, is the causative agent of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T-cell leukaemia/lymphoma (ATLL).
A Gessain   +37 more
core   +1 more source

No association of CTLA-4 polymorphisms with susceptibility to Behcet disease [PDF]

open access: yes, 2009
Background: Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) is a key negative regulator of T lymphocytes and has been shown to be associated with a number of autoimmune diseases. The present study was performed to assess the association between CTLA-
Du, L.   +4 more
core   +5 more sources

Current standardized therapeutic approach for uveitis in Japan

open access: yesImmunological Medicine, 2019
Uveitis is an ocular disease associated with systemic immune-mediated diseases such as rheumatoid arthritis, inflammatory bowel disease and ankylosing spondylitis; and infectious diseases.
Kazuichi Maruyama
doaj   +1 more source

A Review of the Various Roles and Participation Levels of B-Cells in Non-Infectious Uveitis

open access: yesFrontiers in Immunology, 2021
Non-infectious uveitis is an inflammatory disorder of the eye that accounts for severe visual loss without evident infectious agents. While T cells are supposed to dominate the induction of inflammation in non-infectious uveitis, the role of B cells in ...
Lei Zhu, Binyao Chen, Wenru Su
doaj   +1 more source

Corticosteroid implants for chronic non-infectious uveitis. [PDF]

open access: yes, 2016
BACKGROUND: Uveitis is a term used to describe a heterogeneous group of intraocular inflammatory diseases of the anterior, intermediate, and posterior uveal tract (iris, ciliary body, choroid).
Brady, Christopher J   +7 more
core   +2 more sources

Clinical utility of aqueous humor polymerase chain reaction and serologic testing for suspected infectious uveitis: a single-center retrospective study in South Korea

open access: yesBMC Ophthalmology, 2020
Background This study aimed to assess and compare the clinical value of aqueous humor polymerase chain reaction (PCR) and serologic tests in patients diagnosed with suspected infectious uveitis.
Wungrak Choi   +7 more
doaj   +1 more source

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. [PDF]

open access: yes, 2017
Cancer immunotherapy has transformed the treatment of cancer. However, increasing use of immune-based therapies, including the widely used class of agents known as immune checkpoint inhibitors, has exposed a discrete group of immune-related adverse ...
Abdallah, K.   +80 more
core   +2 more sources

Autoimmunity, Autoinflammation, and Infection in Uveitis [PDF]

open access: yes, 2018
Funding/Support: No funding or grant support. Financial Disclosures: John V. Forrester has received an honorarium for lecturing from Janssen (London, UK). Lucia Kuffova has undertaken consultancy work for Abbvie (London, UK). Andrew D.
Dick, Andrew D.   +2 more
core   +4 more sources

Incidence, prevalence, and risk factors of infectious uveitis and scleritis in the United States: A claims-based analysis.

open access: yesPLoS ONE, 2020
BackgroundOcular inflammation causes significant visual morbidity in the United States, yet little is known about the epidemiology of infectious uveitis and scleritis. This study aims to evaluate the epidemiology of infectious uveitis/scleritis employing
Youning Zhang   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy